KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares RepurchasedShort-Term Debt repayments
Ratios

Emergent BioSolutions (EBS) Shares Repurchased (2017 - 2025)

Emergent BioSolutions (EBS) has 7 years of Shares Repurchased data on record, last reported at $9.1 million in Q4 2025.

  • For Q4 2025, Shares Repurchased changed N/A year-over-year to $9.1 million; the TTM value through Dec 2025 reached $18.0 million, changed N/A, while the annual FY2025 figure was $24.9 million, N/A changed from the prior year.
  • Shares Repurchased reached $9.1 million in Q4 2025 per EBS's latest filing, up from $8.9 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $106.0 million in Q4 2021 and bottomed at $200000.0 in Q4 2022.
  • Average Shares Repurchased over 3 years is $34.4 million, with a median of $16.8 million recorded in 2022.
  • The widest YoY moves for Shares Repurchased: up 99.81% in 2022, down 99.81% in 2022.
  • A 3-year view of Shares Repurchased shows it stood at $106.0 million in 2021, then tumbled by 99.81% to $200000.0 in 2022, then surged by 4450.0% to $9.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Repurchased were $9.1 million in Q4 2025, $8.9 million in Q3 2025, and $200000.0 in Q4 2022.